These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22323410)

  • 1. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program.
    Pittas AG; Nelson J; Mitri J; Hillmann W; Garganta C; Nathan DM; Hu FB; Dawson-Hughes B;
    Diabetes Care; 2012 Mar; 35(3):565-73. PubMed ID: 22323410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program.
    Mitri J; Nelson J; Ruthazer R; Garganta C; Nathan DM; Hu FB; Dawson-Hughes B; Pittas AG;
    Eur J Clin Nutr; 2014 Mar; 68(3):376-83. PubMed ID: 24448494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program.
    Ceglia L; Nelson J; Ware J; Alysandratos KD; Bray GA; Garganta C; Nathan DM; Hu FB; Dawson-Hughes B; Pittas AG;
    Eur J Nutr; 2017 Feb; 56(1):161-170. PubMed ID: 26525562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women.
    Schafer AL; Napoli N; Lui L; Schwartz AV; Black DM;
    Diabet Med; 2014 May; 31(5):564-9. PubMed ID: 24299116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
    PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women.
    Pittas AG; Sun Q; Manson JE; Dawson-Hughes B; Hu FB
    Diabetes Care; 2010 Sep; 33(9):2021-3. PubMed ID: 20805275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
    Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Vitamin D Deficiency and Incident Frailty in Older Women: The Role of Cardiometabolic Diseases.
    Buta B; Choudhury PP; Xue QL; Chaves P; Bandeen-Roche K; Shardell M; Semba RD; Walston J; Michos ED; Appel LJ; McAdams-DeMarco M; Gross A; Yasar S; Ferrucci L; Fried LP; Kalyani RR
    J Am Geriatr Soc; 2017 Mar; 65(3):619-624. PubMed ID: 28008596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential associations of ferritin and 25-hydroxyvitamin D with fasting glucose and diabetes risk in community dwelling older men.
    Carrivick S; Alfonso H; Golledge J; Clancy P; Flicker L; Gunton JE; Hankey GJ; Almeida OP; Norman PE; Yeap BB
    Diabetes Metab Res Rev; 2019 Oct; 35(7):e3172. PubMed ID: 30997951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D Supplementation and Prevention of Type 2 Diabetes.
    Pittas AG; Dawson-Hughes B; Sheehan P; Ware JH; Knowler WC; Aroda VR; Brodsky I; Ceglia L; Chadha C; Chatterjee R; Desouza C; Dolor R; Foreyt J; Fuss P; Ghazi A; Hsia DS; Johnson KC; Kashyap SR; Kim S; LeBlanc ES; Lewis MR; Liao E; Neff LM; Nelson J; O'Neil P; Park J; Peters A; Phillips LS; Pratley R; Raskin P; Rasouli N; Robbins D; Rosen C; Vickery EM; Staten M;
    N Engl J Med; 2019 Aug; 381(6):520-530. PubMed ID: 31173679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D Supplementation for Prevention of Cancer: The D2d Cancer Outcomes (D2dCA) Ancillary Study.
    Chatterjee R; Fuss P; Vickery EM; LeBlanc ES; Sheehan PR; Lewis MR; Dolor RJ; Johnson KC; Kashyap SR; Nelson J; Pittas AG;
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2767-2778. PubMed ID: 33693713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies.
    Bao Y; Ng K; Wolpin BM; Michaud DS; Giovannucci E; Fuchs CS
    Br J Cancer; 2010 Apr; 102(9):1422-7. PubMed ID: 20389298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
    Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
    JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
    Perreault L; Pan Q; Mather KJ; Watson KE; Hamman RF; Kahn SE;
    Lancet; 2012 Jun; 379(9833):2243-51. PubMed ID: 22683134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease.
    Kendrick J; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Chonchol M;
    Am J Kidney Dis; 2012 Oct; 60(4):567-75. PubMed ID: 22621970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).
    Gagnon C; Lu ZX; Magliano DJ; Dunstan DW; Shaw JE; Zimmet PZ; Sikaris K; Ebeling PR; Daly RM
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1953-61. PubMed ID: 22442263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium plus vitamin D supplementation and the risk of breast cancer.
    Chlebowski RT; Johnson KC; Kooperberg C; Pettinger M; Wactawski-Wende J; Rohan T; Rossouw J; Lane D; O'Sullivan MJ; Yasmeen S; Hiatt RA; Shikany JM; Vitolins M; Khandekar J; Hubbell FA;
    J Natl Cancer Inst; 2008 Nov; 100(22):1581-91. PubMed ID: 19001601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.
    Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y
    JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.